Australia markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.67+0.17 (+2.62%)
At close: 04:00PM EST
6.71 +0.04 (+0.60%)
After hours: 07:35PM EST
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
-231,362
-65,578
-89,127
-70,279
-98,942
Depreciation & amortisation
6,554
5,947
6,578
7,603
7,862
Stock-based compensation
23,865
20,222
8,824
8,344
16,641
Change in working capital
-32,914
41,530
-23,197
-24,627
11,799
Accounts receivable
1,250
9,387
-7,602
-1,785
-
Accounts payable
1,331
9,362
-1,159
-1,460
-353
Other working capital
-235,725
-2,878
-94,201
-77,522
-64,791
Other non-cash items
4,965
2,041
3,312
2,336
-214
Net cash provided by operating activities
-227,787
6,688
-93,610
-76,520
-62,854
Cash flows from investing activities
Investments in property, plant and equipment
-7,938
-9,566
-591
-1,002
-1,937
Purchases of investments
-65,767
-95,971
-218,284
-46,420
-21,832
Sales/maturities of investments
162,643
169,625
59,984
16,904
136,087
Net cash used for investing activities
89,688
64,088
-158,891
-30,518
112,318
Cash flows from financing activities
Debt repayment
-2,855
-948
-
-
-
Common stock issued
100,000
0
268,641
61,215
61
Common stock repurchased
-
-
0
0
-197
Other financing activities
-
-
19,900
-425
-
Net cash used provided by (used for) financing activities
124,225
1,178
303,424
86,231
268
Net change in cash
-13,874
71,954
50,923
-20,807
49,732
Cash at beginning of period
227,460
116,049
65,126
85,933
36,201
Cash at end of period
213,586
188,002
116,049
65,126
85,933
Free cash flow
Operating cash flow
-227,787
6,688
-93,610
-76,520
-62,854
Capital expenditure
-7,938
-9,566
-591
-1,002
-1,937
Free cash flow
-235,725
-2,878
-94,201
-77,522
-64,791